Saundra Pelletier
About Saundra Pelletier
Saundra Pelletier is the CEO and interim Chair of the Board with over 25 years of experience in the pharmaceutical industry, recognized for her contributions to women's healthcare and reproductive health.
Title and Current Role
Saundra Pelletier serves as the Chief Executive Officer and interim Chair of the Board. With over 25 years of experience in the pharmaceutical industry, she has led efforts to launch and expand pharmaceutical brands worldwide, especially focusing on female healthcare.
Pharmaceutical Industry Experience
Saundra Pelletier has accumulated over 25 years of experience in the pharmaceutical industry. During her tenure as an Executive Director at Woman Care Global, she was instrumental in establishing a sustainable supply chain for reproductive healthcare in low- and middle-income countries. Additionally, she has worked at G.D. Searle as a Global Franchise Leader. At G.D. Searle, she managed a $250 million business unit and oversaw international partnerships.
Advocacy and Speaking Engagements
Saundra Pelletier is a known advocate for innovation in women's healthcare. She is a published author, keynote speaker, and executive coach. She has also appeared at prominent forums such as TEDx San Diego, Harvard School of Public Health, Davos World Economic Forum, and the Clinton Global Initiative.
Recognition and Awards
Saundra Pelletier has been recognized for her contributions to reproductive health and women's empowerment. She was named a New Champion for Reproductive Health by the United Nations Foundation. Her accolades include the Athena San Diego’s Pinnacle Award for Life Sciences and the 2019 Businesswoman of the Year award by the San Diego Business Journal. Moreover, she was listed in Inc. Magazine’s 2020 Female Founders 100 List.
Board Memberships and Directorship
Saundra Pelletier has served as a Director at TRACON Pharmaceuticals, Inc., where she focused on developing novel targeted therapeutics for cancer. Her extensive board experience highlights her role in steering companies towards innovation and growth in the healthcare sector.